Letterer-Siwe disease
https://doi.org/10.51523/2708-6011.2018-15-2-20
Abstract
About the Authors
I. F. ShalygaBelarus
G. V. Tishchenko
Belarus
L. A. Martemyanova
Belarus
S. Yu. Turchenko
Belarus
Yu. N. Avizhets
Belarus
References
1. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672-2681.
2. Da Costa CE, SzuhaiK, van Eijk R. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer. 2009;48:239-249.
3. Calonje E, Brenn T, Lazar A, McKee PH. McKee's pathology of the skin: with clinical correlations. 4th ed. Saunders: Elsevier; 2012. р.1392-1397.
4. Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med. 2008;14(1):81-87.
5. Fletcher CDM. Diagnostic histopathology of tumor in 2 vol. 4th ed. Saunders: Elsevier; 2013. vol.2. p. 1459-1461.
6. Folpe AL, Inwards CY. Bone and soft tissue pathology. Saunders: Elsevier, 2015. p. 437-441.
Review
For citations:
Shalyga I.F., Tishchenko G.V., Martemyanova L.A., Turchenko S.Yu., Avizhets Yu.N. Letterer-Siwe disease. Health and Ecology Issues. 2018;(2):99-103. (In Russ.) https://doi.org/10.51523/2708-6011.2018-15-2-20